Publicaciones en las que colabora con Carlos Jesús Mackintosh Ginel (9)

2013

  1. WEE1 accumulation and deregulation of S-phase proteins mediate MLN4924 potent inhibitory effect on Ewing sarcoma cells

    Oncogene, Vol. 32, Núm. 11, pp. 1441-1451

2012

  1. 1q gain and CDT2 overexpression underlie an aggressive and highly proliferative form of Ewing sarcoma

    Oncogene, Vol. 31, Núm. 10, pp. 1287-1298

  2. Delineation of commonly deleted chromosomal regions in meningiomas by high-density single nucleotide polymorphism genotyping arrays

    Genes Chromosomes and Cancer, Vol. 51, Núm. 6, pp. 606-617

2010

  1. The clinical relevance of molecular genetics in soft tissue sarcomas

    Advances in Anatomic Pathology, Vol. 17, Núm. 3, pp. 162-181

2009

  1. Stable interference of EWS-FLI1 in an Ewing sarcoma cell line impairs IGF-1/IGF-1R signalling and reveals TOPK as a new target

    British Journal of Cancer, Vol. 101, Núm. 1, pp. 80-90

2008

  1. A pivotal role for heat shock protein 90 in Ewing sarcoma resistance to anti-insulin-like growth factor 1 receptor treatment: In vitro and in vivo study

    Cancer Research, Vol. 68, Núm. 15, pp. 6260-6270

  2. Array-based comparative genomic hybridization of mapped BAC DNA clones to screen for chromosome 14 copy number abnormalities in meningiomas

    European Journal of Human Genetics, Vol. 16, Núm. 12, pp. 1450-1458

2006

  1. Insulin-like growth factor I receptor pathway inhibition by ADW742, alone or in combination with imatinib, doxorubicin, or vincristine, is a novel therapeutic approach in Ewing tumor

    Clinical Cancer Research, Vol. 12, Núm. 11 I, pp. 3532-3540

2005

  1. Imatinib is not a potential alternative treatment for uterine leiomyosarcoma (multiple letters)

    Clinical Cancer Research